We serve Chemical Name:2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE CAS:930303-55-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE
CAS.NO:930303-55-2
Synonyms:2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE
Molecular Formula:C8H5ClN2O
Molecular Weight:180.59100
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.01000
Exact Mass:180.00900
LogP:1.98880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE Use and application,2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE technical grade,usp/ep/jp grade.
Related News: Other possible health risks of PFAS include kidney cancer, testicular cancer and high blood pressure, the researchers added. 2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE manufacturer China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. 2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE supplier In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China. 2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE vendor China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. 2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE factory In these situations, the API is not a single substance but the culmination of various ingredients.
